Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.
about
Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutantsCurrent Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of CancerAssessment, origin, and implementation of breath volatile cancer markers.The scent of disease: volatile organic compounds of the human body related to disease and disorderQuantitative analysis of volatile organic compounds released and consumed by rat L6 skeletal muscle cells in vitroBreath analysis in disease diagnosis: methodological considerations and applications.Advances in electronic-nose technologies developed for biomedical applications.Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.Noninvasive detection of lung cancer by analysis of exhaled breath.Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation.Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.Analysis of volatile organic compounds liberated and metabolised by human umbilical vein endothelial cells (HUVEC) in vitro.Unique volatolomic signatures of TP53 and KRAS in lung cells.Urinary Volatile Organic Compounds for the Detection of Prostate CancerAnalysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice.TD-GC-MS Investigation of the VOCs Released from Blood Plasma of Dogs with Cancer.Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles.A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines.Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.Gas signatures from Escherichia coli and Escherichia coli-inoculated human whole blood.Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical propertiesMore than apples and oranges--detecting cancer with a fruit fly's antennaDevelopment of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph ColumnsBlood volatile compounds as biomarkers for colorectal cancer.Volatile metabolomic signature of human breast cancer cell lines.Lung cancer biomarkers in exhaled breath.Noninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis.Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease.Classification of lung cancer histology by gold nanoparticle sensors.Hybrid volatolomics and disease detection.Nanoscale Sensor Technologies for Disease Detection via Volatolomics.Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.Advanced online monitoring of cell culture off-gas using proton transfer reaction mass spectrometry.Quantification by SIFT-MS of acetaldehyde released by lung cells in a 3D model.A study of enzymatic activity in cell cultures via the analysis of volatile biomarkers.Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's "chemical odor fingerprint".Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.Exhaled gases online measurements for esophageal cancer patients and healthy people by proton transfer reaction mass spectrometry.Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.
P2860
Q24817107-13FE621D-4359-4E4D-A2E6-32969F782B41Q26796389-48E5697F-89B5-44E6-8475-5CA2A66A10F8Q27692565-D60B604D-D716-427B-826F-C3C0C49A6503Q28243639-C7A2B699-27BA-489C-BB9D-094D39CB5F12Q28601030-F65C1054-CAC3-469A-9AFE-2FD7FFF40198Q30434697-56E6672F-F68E-49CD-8473-6E837914F769Q30470504-CB99F00C-4971-49DB-A8C2-203350D045E8Q33435548-8491CE2E-8DDD-4802-B0CA-1674AEAF6552Q33507435-A0036264-C886-43DF-AC0E-7434639C4716Q34310915-ECED029C-5B93-4884-8AE9-54B3B52F5771Q34648188-2190C2FC-BD0A-49DA-AA10-32861C1E708CQ34840709-EC9D4905-3C5A-4E21-987B-6392F54A5A06Q34900602-9DF2C355-63EA-4E37-A84D-0B97608AC956Q35678408-BE949DAE-DBF9-4E72-925B-331630DFEF1AQ35849909-9095EF73-1FC2-45CD-96DC-1E16E1666A2EQ35854350-EF5699D8-4DE5-4D13-A42A-ED5CAD240628Q35911795-5A4757D4-F3D6-4279-987B-3750074D27BAQ36011615-7C6035EF-529F-42C3-9C40-B42933EEBFB3Q36012613-1AE24DD3-CD12-40FE-93E9-FC4655F19E2CQ37001025-70CEDD7D-29DF-48A0-B06A-C09342AD7283Q37028444-A3EDD64C-7BDA-4EE8-9EF1-ED3D64509074Q37138493-9AE9B7AA-9F51-400E-B510-A174CF36A180Q37434154-D310C14D-B891-4B75-89DD-89DAC75CFA62Q37467282-48951176-F7C0-4EEC-B570-725DECDED8B3Q37591469-E538922B-C9DF-4D74-A17E-99DEEAAC88EAQ37678902-285E520D-DBC9-4F37-9DCE-CAF414A4EDBEQ37853184-40319619-5F94-4A14-825E-04D59EA538ECQ38112480-79794CE8-A1E6-4E78-8681-10CD54B861F1Q38182688-24671E63-828D-4A8D-9A4A-88BC5AADEC39Q38286916-254EF704-B986-4FE2-8225-BF808F5E4441Q38559382-6D2A4FE7-2508-4A78-9FB8-E20ECC7571B9Q38602462-1F1F2206-56F6-404F-AC68-C49A45F2CEFBQ38779486-9F0B3049-7732-4250-AEBA-6A650EDDDD99Q39038574-ECF1C412-0005-4BED-BE18-30FD8EC76573Q39247847-9A9B3DC8-FE42-4C82-AF37-59657A15969EQ39289143-31049EFD-E438-4B11-AB77-496463406072Q39367135-3C0555B1-B36F-4A4F-9E9A-5781B70AAD0EQ39893495-E140E375-951D-46C2-AD08-9FFBE7F1FAFAQ39904147-33920970-ADFC-4118-B47D-3017B7CA1BC7Q41577330-90D729BC-6F99-4D72-B25A-A65DAF1C4A6B
P2860
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Release of volatile organic co ...... cer cell line CALU-1 in vitro.
@ast
Release of volatile organic co ...... cer cell line CALU-1 in vitro.
@en
type
label
Release of volatile organic co ...... cer cell line CALU-1 in vitro.
@ast
Release of volatile organic co ...... cer cell line CALU-1 in vitro.
@en
prefLabel
Release of volatile organic co ...... cer cell line CALU-1 in vitro.
@ast
Release of volatile organic co ...... cer cell line CALU-1 in vitro.
@en
P2093
P2860
P50
P921
P356
P1476
Release of volatile organic co ...... cer cell line CALU-1 in vitro.
@en
P2093
Andreas Sponring
Anton Amann
Clemens Ager
Jakob Troppmair
Tomas Mikoviny
P2860
P2888
P356
10.1186/1475-2867-8-17
P577
2008-11-24T00:00:00Z
P5875
P6179
1039555852